![]() |
市場調查報告書
商品編碼
1954620
壓力/接觸式安全採血針市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2026-2034 年)Pressure/Contact-activated Safety Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球壓力/接觸式安全採血針市場規模為 4.5623 億美元,預計 2026 年將成長至 5.0267 億美元,到 2034 年將達到 11.6418 億美元。這意味著在預測期內,複合年增長率 (CAGR) 為 11.07%。北美地區在 2025 年將以 42.37% 的市場佔有率(相當於 1.9332 億美元)引領市場,這主要得益於對先進設備的強勁需求以及針對慢性病監測產品的高額報銷政策。
壓力/接觸式安全採血針是一次性使用的毛細血管採血裝置,用於糖尿病管理和診斷。它們具有自動收縮功能,只需對指尖施加輕微壓力即可啟動。其易用性、減少疼痛和出血量少是推動其在醫院、診所和家庭醫療保健機構廣泛應用的主要因素。
市場動態
驅動因素
全球糖尿病患者人數的不斷增加是推動市場發展的主要因素。頻繁的血糖監測對於有效管理糖尿病至關重要,這也推動了對安全採血針的需求。壓力式採血針可提供穩定的穿刺深度,降低針刺傷風險,並方便在家中進行自我監測。根據國際糖尿病聯盟(2025年7月)的數據,2024年全球有5.89億成年糖尿病患者,預計到2050年這一數字將達到8.53億。這凸顯了對採血針的持續需求。
人們對安全糖尿病照護意識的提高以及微創技術的普及,進一步推動了醫院、診所和家庭護理領域的市場成長。
市場限制因子
市場面臨依鈕式採血針的競爭,這類採血針能夠提供更可預測的穿刺深度和符合人體工學的設計。多層次深度調節和靜音機制等創新技術正在提高採血針的普及率,尤其是在老年人和神經功能障礙患者中,這限制了壓力/接觸式採血針的市場成長。
機會
向家庭醫療保健監測的轉變帶來了充滿希望的機會。由於人們對經濟便利的血糖監測的需求日益增長,自我血糖監測也越來越普遍。無需啟動依鈕的接觸式採血針非常適合未經訓練的用戶,包括老年人和兒童患者。例如,2023 年的一項研究報告稱,印度有 35% 的患者在家中使用血糖儀進行自我血糖監測,這表明家用診斷工具的需求正在增長。
挑戰
在中低收入國家,血糖監測工具的普及率低,且價格昂貴,這限制了市場擴張。在孟加拉等醫療基礎設施欠發達的國家,公共醫療支出僅佔 GDP 的 2.34%,限制了其普及。此外,缺乏相關知識以及製造商不願進入這些地區也是市場成長面臨的挑戰。
市場趨勢
超細針尖技術和人體工學設計的融合是主要趨勢。採用 21G 至 30G 超細針頭和彈簧式裝置的採血針可實現幾乎無痛的採血。使用可生物降解組件的可持續設計正在興起,以減少對環境的影響。同時,監管標準仍建議在臨床環境中使用設計安全、鋒利的器械。
依切口類型:針式採血針因其安全性高、疼痛輕、易於使用而佔主導地位。刀片式採血針的需求也在成長,尤其是在新生兒和多項檢測應用。
依年齡層:雖然由於糖化血紅素 (HbA1c)、膽固醇和凝血功能檢測的需求,採血針在成人的應用最為普遍,但 1 型糖尿病兒童的使用也在增加。
依應用:由於自我管理趨勢,血糖監測引領市場,其次是血紅素檢測,此項檢測正在快速成長。這主要受糖化血紅蛋白 (HbA1c) 檢測需求的驅動。
依規格:由於需要盡可能減少傷口和採集少量血液,28G 以上規格的採血針佔主導地位。 22G 及以下規格的採血針則用於需要較大樣本量的臨床實驗室。
依分銷管道:預計到 2025 年,醫院藥房將佔主導地位,但由於便利性和電子商務的日益普及,預計在線藥房的複合年增長率 (CAGR) 將最高。
The global pressure/contact-activated safety lancet market was valued at USD 456.23 million in 2025 and is projected to grow to USD 502.67 million in 2026, reaching USD 1,164.18 million by 2034, representing a CAGR of 11.07% during the forecast period. North America dominated the market in 2025 with a 42.37% share, equivalent to USD 193.32 million, driven by strong demand for advanced devices and significant reimbursement for chronic disease monitoring products.
Pressure/contact-activated safety lancets are single-use, disposable devices used for capillary blood sampling in diabetes management and diagnostic applications. They feature automatic retraction and are activated when slight pressure is applied on the fingertip. Their ease of use, limited pain, and minimal blood loss are key factors driving adoption in hospitals, clinics, and home healthcare settings.
Market Dynamics
Drivers
The rising prevalence of diabetes globally is a major market driver. Frequent blood glucose monitoring is required for effective diabetes management, fueling the demand for safety lancets. Pressure-activated lancets offer consistent penetration depth, reduced risk of needlestick injuries, and convenience for self-monitoring at home. According to the International Diabetes Federation (July 2025), 589 million adults lived with diabetes globally in 2024, a number projected to reach 853 million by 2050, highlighting the sustained need for lancets.
Increasing awareness about safe diabetes care and adoption of minimally invasive technologies further drives market growth across hospitals, clinics, and home care.
Restraints
The market faces competition from button-activated lancets, which provide more predictable depth penetration and ergonomic designs. Innovations such as multi-depth adjustment and quieter mechanisms have increased their adoption, particularly among elderly or neuropathic patients, limiting the market growth of pressure/contact-activated devices.
Opportunities
The shift toward home healthcare monitoring offers lucrative opportunities. Self-monitoring of blood glucose is increasing due to the need for cost-effective and convenient care. Contact-activated lancets, eliminating the need for activation buttons, are ideal for untrained users, including elderly and pediatric patients. For instance, a 2023 study reported that 35% of patients in India self-monitored blood glucose at home using glucometers, demonstrating rising demand for at-home diagnostic tools.
Challenges
Limited accessibility and affordability in low- and middle-income countries restrict market expansion. Countries with less-developed healthcare infrastructure, such as Bangladesh, spend as little as 2.34% of GDP on public healthcare, limiting adoption. Awareness gaps and hesitation among manufacturers to enter these regions also pose growth challenges.
Market Trends
Integration of ultra-fine gauge technology and ergonomic designs is a key trend. Lancets with 21G-30G ultra-thin needles and spring-loaded mechanisms provide nearly painless sampling. Sustainability-focused designs using biodegradable components are emerging to reduce environmental impact, while regulatory standards continue to favor safety-engineered sharps in clinical settings.
By Incision Type: Needle lancets dominate due to safety, less pain, and ease of use. Blade lancets are also growing, especially for neonatal and multi-test applications.
By Age Group: Adults dominate adoption, driven by HbA1c, cholesterol, and coagulation testing, while pediatric usage is increasing among Type 1 diabetes patients.
By Application: Blood glucose monitoring leads the market, driven by self-monitoring trends, followed by hemoglobin testing, which is growing rapidly due to HBA1C testing demand.
By Gauge Size: Lancets above 28G dominate for minimal trauma and small blood volume needs. 22G and below are used in clinical labs requiring higher sample yields.
By Distribution Channel: Hospital pharmacies lead in 2025, while online pharmacies are expected to register the highest CAGR due to convenience and growing e-commerce penetration.
Competitive Landscape
The market is moderately consolidated. Leading players include BD, HTL-STREFA, Cardinal Health, Medline Industries, Braun SE, Aeras Medical, and Owen Mumford. Strategic initiatives such as new product launches, geographic expansion, and promotional activities at conferences strengthen their market position.
Key Developments:
Conclusion
The global pressure/contact-activated safety lancet market, valued at USD 456.23 million in 2025, is projected to grow to USD 502.67 million in 2026 and reach USD 1,164.18 million by 2034 at a CAGR of 11.07%. Growth is driven by rising diabetes prevalence, demand for self-monitoring, adoption of ultra-fine gauge and ergonomic designs, and expanding home healthcare trends. While competition from button-activated lancets and limited accessibility in low-income regions pose challenges, technological innovation, increasing home diagnostics, and favorable reimbursement policies are expected to sustain market expansion through 2034.
Segmentation By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region
By Incision Type * Needle
By Age Group * Adult
By Application * Blood Glucose Monitoring
By Gauge Size * 22G and Below
By Distribution Channel * Hospital Pharmacies
By Region * North America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)